MICHAEL HILL: Open Payments
NPI 1104168327 · BLUFF CITY, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$633 in 34 payments from 7 companies in 2025. Trend: 2023 $674 · 2024 $595 · 2025 $633
Food & beverage: $633
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 16 | $293 |
| GlaxoSmithKline, LLC. | 8 | $139 |
| Lilly USA, LLC | 4 | $93 |
| Novo Nordisk Inc | 2 | $36 |
| ABBVIE INC. | 2 | $30 |
| Ardelyx, Inc. | 1 | $22 |
| Viatris Specialty LLC | 1 | $21 |
Products named: TRELEGY ELLIPTA, BREZTRI, MOUNJARO, FARXIGA, AIRSUPRA, Ozempic, VRAYLAR, IBSRELA.
Industry payments across TN — which companies pay providers there.
